Avdoralimab (Anti-Complement C5aR1)

Synonyms: IPH 5401; Anti-C5aR1 mAb

Avdoralimab (Anti-Complement C5aR1) is a fully human IgGκ monoclonal antibody targeting the complement C5a receptor 1 (C5aR1), that prevents its binding to C5a. Avdoralimab can be used for complement-driven inflammatory diseases and solid tumours research. MW: 145.5 KD.

Avdoralimab (Anti-Complement C5aR1)

Purity & Quality Control

Biological Activity

Description Avdoralimab (Anti-Complement C5aR1) is a fully human IgGκ monoclonal antibody targeting the complement C5a receptor 1 (C5aR1), that prevents its binding to C5a. Avdoralimab can be used for complement-driven inflammatory diseases and solid tumours research. MW: 145.5 KD.

Product Details

CAS No. 2226393-85-5
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Avdoralimab (Anti-Complement C5aR1) | Avdoralimab (Anti-Complement C5aR1) supplier | purchase Avdoralimab (Anti-Complement C5aR1) | Avdoralimab (Anti-Complement C5aR1) cost | Avdoralimab (Anti-Complement C5aR1) manufacturer | order Avdoralimab (Anti-Complement C5aR1) | Avdoralimab (Anti-Complement C5aR1) distributor